Abeona Therapeutics Inc’s recently made public that its Director Alvino Mark unloaded Company’s shares for reported $45440.0 on May 16 ’25. In the deal valued at $5.68 per share,8,000 shares were sold. As a result of this transaction, Alvino Mark now holds 92,435 shares worth roughly $0.59 million.
Then, Alvino Mark bought 8,000 shares, generating $45,423 in total proceeds.
Before that, Seshadri Vishwas sold 25,000 shares. Abeona Therapeutics Inc shares valued at $119,500 were divested by the Chief Executive Officer at a price of $4.78 per share. As a result of the transaction, Seshadri Vishwas now holds 1,355,322 shares, worth roughly $8.7 million.
Oppenheimer initiated its Abeona Therapeutics Inc [ABEO] rating to an Outperform in a research note published on March 05, 2025; the price target was $16. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Stifel began covering ABEO with “Buy” recommendation on May 30, 2024. Cantor Fitzgerald revised its rating on November 11, 2020. It rated ABEO as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of ABEO
On Tuesday, Abeona Therapeutics Inc [NASDAQ:ABEO] saw its stock jump 3.05% to $6.42. Over the last five days, the stock has gained 14.03%. Abeona Therapeutics Inc shares have risen nearly 15.26% since the year began. Nevertheless, the stocks have risen 39.57% over the past one year. While a 52-week high of $7.32 was reached on 04/30/25, a 52-week low of $3.93 was recorded on 04/09/25. SMA at 50 days reached $5.27, while 200 days put it at $5.63.
Levels Of Support And Resistance For ABEO Stock
The 24-hour chart illustrates a support level at 6.24, which if violated will result in even more drops to 6.05. On the upside, there is a resistance level at 6.52. A further resistance level may holdings at 6.62. The Relative Strength Index (RSI) on the 14-day chart is 62.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 33.67%. Stochastics %K at 55.61% indicates the stock is a holding.
The most recent change occurred on September 18, 2020 when B. Riley FBR began covering the stock and recommended ‘”a Buy”‘ rating along with a $5 price target.
